Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 42 | 2021 | 229 | 7.480 |
Why?
|
Hyperthermia, Induced | 24 | 2021 | 53 | 6.490 |
Why?
|
Liposomes | 16 | 2022 | 107 | 6.110 |
Why?
|
Temperature | 32 | 2021 | 341 | 4.150 |
Why?
|
Drug Delivery Systems | 17 | 2022 | 236 | 4.130 |
Why?
|
Models, Biological | 17 | 2016 | 981 | 3.310 |
Why?
|
Liver Neoplasms | 21 | 2018 | 334 | 3.300 |
Why?
|
Doxorubicin | 15 | 2022 | 231 | 3.070 |
Why?
|
Computer Simulation | 25 | 2021 | 706 | 2.230 |
Why?
|
Ablation Techniques | 5 | 2017 | 33 | 2.220 |
Why?
|
Liver | 16 | 2016 | 1118 | 2.190 |
Why?
|
Electrodes | 20 | 2009 | 147 | 1.960 |
Why?
|
Microwaves | 6 | 2017 | 31 | 1.800 |
Why?
|
Neoplasms | 16 | 2021 | 1667 | 1.750 |
Why?
|
Nanoparticles | 8 | 2022 | 254 | 1.670 |
Why?
|
Antibiotics, Antineoplastic | 9 | 2022 | 82 | 1.440 |
Why?
|
Hot Temperature | 11 | 2015 | 152 | 1.330 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 1070 | 1.210 |
Why?
|
Surgery, Computer-Assisted | 5 | 2011 | 52 | 1.090 |
Why?
|
Finite Element Analysis | 11 | 2009 | 55 | 1.070 |
Why?
|
Swine | 20 | 2017 | 672 | 1.060 |
Why?
|
Heart | 8 | 2021 | 850 | 1.030 |
Why?
|
Body Temperature | 8 | 2012 | 116 | 1.020 |
Why?
|
Skin | 4 | 2009 | 451 | 0.990 |
Why?
|
Animals | 49 | 2021 | 20881 | 0.950 |
Why?
|
Electric Conductivity | 6 | 2014 | 87 | 0.900 |
Why?
|
Radio Waves | 9 | 2009 | 21 | 0.880 |
Why?
|
Models, Cardiovascular | 9 | 2011 | 133 | 0.790 |
Why?
|
Carcinoma, Lewis Lung | 2 | 2019 | 20 | 0.760 |
Why?
|
Ultrasonography | 4 | 2018 | 453 | 0.730 |
Why?
|
Algorithms | 11 | 2017 | 1196 | 0.680 |
Why?
|
Thermal Conductivity | 6 | 2014 | 24 | 0.670 |
Why?
|
Burns | 3 | 2009 | 83 | 0.660 |
Why?
|
Drug Liberation | 2 | 2021 | 17 | 0.660 |
Why?
|
Nanomedicine | 2 | 2019 | 19 | 0.650 |
Why?
|
Therapy, Computer-Assisted | 4 | 2019 | 57 | 0.650 |
Why?
|
Optical Imaging | 1 | 2019 | 46 | 0.630 |
Why?
|
Fluorescence | 1 | 2018 | 104 | 0.620 |
Why?
|
Blood-Brain Barrier | 1 | 2018 | 99 | 0.620 |
Why?
|
Hepatectomy | 5 | 2010 | 58 | 0.610 |
Why?
|
Fever | 1 | 2018 | 96 | 0.610 |
Why?
|
Cardiac Surgical Procedures | 4 | 2007 | 450 | 0.610 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2015 | 163 | 0.610 |
Why?
|
Microfluidics | 1 | 2017 | 22 | 0.600 |
Why?
|
Cryosurgery | 3 | 2008 | 53 | 0.600 |
Why?
|
Equipment Design | 11 | 2009 | 500 | 0.580 |
Why?
|
Myocardium | 4 | 2008 | 1204 | 0.560 |
Why?
|
Cardiac Catheterization | 3 | 2007 | 419 | 0.520 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 2 | 2012 | 3 | 0.510 |
Why?
|
Models, Theoretical | 1 | 2017 | 384 | 0.470 |
Why?
|
Electrocoagulation | 2 | 2010 | 35 | 0.440 |
Why?
|
Humans | 46 | 2021 | 68618 | 0.430 |
Why?
|
Skin Temperature | 2 | 2009 | 24 | 0.420 |
Why?
|
Equipment Failure Analysis | 4 | 2006 | 121 | 0.410 |
Why?
|
Biomedical Engineering | 4 | 2019 | 20 | 0.380 |
Why?
|
In Vitro Techniques | 6 | 2008 | 765 | 0.380 |
Why?
|
Cell Line, Tumor | 7 | 2022 | 1851 | 0.360 |
Why?
|
Kinetics | 3 | 2021 | 1047 | 0.350 |
Why?
|
Plethysmography, Impedance | 1 | 2010 | 17 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 239 | 0.340 |
Why?
|
Cattle | 6 | 2010 | 475 | 0.330 |
Why?
|
Polyethylene Glycols | 3 | 2019 | 149 | 0.330 |
Why?
|
Perfusion | 1 | 2008 | 131 | 0.310 |
Why?
|
Biological Transport | 3 | 2021 | 210 | 0.310 |
Why?
|
Blood Vessels | 2 | 2008 | 102 | 0.300 |
Why?
|
Phantoms, Imaging | 4 | 2010 | 189 | 0.290 |
Why?
|
Mice | 10 | 2021 | 8474 | 0.290 |
Why?
|
Cold Temperature | 2 | 2006 | 90 | 0.280 |
Why?
|
Blood Loss, Surgical | 1 | 2007 | 79 | 0.280 |
Why?
|
Time Factors | 6 | 2020 | 4655 | 0.280 |
Why?
|
Regional Blood Flow | 5 | 2014 | 168 | 0.270 |
Why?
|
Therapeutic Irrigation | 1 | 2006 | 63 | 0.270 |
Why?
|
Burns, Electric | 1 | 2006 | 2 | 0.270 |
Why?
|
Thermometers | 2 | 2005 | 13 | 0.270 |
Why?
|
Calorimetry | 1 | 2005 | 21 | 0.260 |
Why?
|
Radiation Injuries | 1 | 2006 | 97 | 0.250 |
Why?
|
Tissue Distribution | 3 | 2021 | 282 | 0.250 |
Why?
|
Thrombosis | 1 | 2006 | 218 | 0.250 |
Why?
|
Artificial Intelligence | 1 | 2005 | 159 | 0.230 |
Why?
|
Heating | 2 | 2017 | 13 | 0.210 |
Why?
|
Mice, Nude | 3 | 2019 | 294 | 0.210 |
Why?
|
Idarubicin | 1 | 2021 | 4 | 0.190 |
Why?
|
Ultrasonic Therapy | 1 | 2021 | 19 | 0.190 |
Why?
|
Skull | 1 | 2021 | 63 | 0.190 |
Why?
|
Cell Survival | 3 | 2013 | 901 | 0.190 |
Why?
|
Catheters | 1 | 2021 | 39 | 0.180 |
Why?
|
Colonic Neoplasms | 1 | 2003 | 299 | 0.180 |
Why?
|
Fluorescent Dyes | 1 | 2021 | 191 | 0.180 |
Why?
|
Electric Impedance | 4 | 2010 | 131 | 0.180 |
Why?
|
Glioma | 1 | 2021 | 140 | 0.180 |
Why?
|
Combined Modality Therapy | 5 | 2017 | 951 | 0.170 |
Why?
|
Female | 12 | 2021 | 38074 | 0.170 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 532 | 0.170 |
Why?
|
Feedback | 3 | 2010 | 90 | 0.160 |
Why?
|
Models, Animal | 4 | 2015 | 252 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2015 | 2223 | 0.160 |
Why?
|
Dogs | 1 | 2018 | 490 | 0.150 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 118 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 201 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2021 | 371 | 0.150 |
Why?
|
Heart Conduction System | 2 | 2010 | 119 | 0.150 |
Why?
|
Area Under Curve | 1 | 2017 | 238 | 0.140 |
Why?
|
Hep G2 Cells | 2 | 2013 | 68 | 0.140 |
Why?
|
Surgical Procedures, Operative | 2 | 2007 | 124 | 0.140 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 172 | 0.130 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2015 | 38 | 0.130 |
Why?
|
Thermography | 2 | 2005 | 20 | 0.130 |
Why?
|
Portal Vein | 2 | 2005 | 46 | 0.120 |
Why?
|
Rabbits | 2 | 2012 | 509 | 0.120 |
Why?
|
Electromagnetic Radiation | 1 | 2014 | 1 | 0.120 |
Why?
|
Reproducibility of Results | 5 | 2006 | 2077 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2005 | 1753 | 0.110 |
Why?
|
Organ Size | 1 | 2013 | 242 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2013 | 91 | 0.110 |
Why?
|
Prostate | 1 | 2014 | 116 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 2 | 2011 | 333 | 0.110 |
Why?
|
Intracellular Space | 1 | 2012 | 42 | 0.110 |
Why?
|
Biological Availability | 1 | 2012 | 79 | 0.110 |
Why?
|
Male | 6 | 2018 | 37321 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 64 | 0.100 |
Why?
|
Melanoma, Experimental | 1 | 2013 | 95 | 0.100 |
Why?
|
Ventricular Fibrillation | 2 | 2010 | 85 | 0.100 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2012 | 151 | 0.100 |
Why?
|
Bioengineering | 1 | 2011 | 5 | 0.090 |
Why?
|
Models, Statistical | 4 | 2010 | 448 | 0.090 |
Why?
|
Sepharose | 1 | 2010 | 18 | 0.090 |
Why?
|
Hemostasis, Surgical | 2 | 2007 | 18 | 0.090 |
Why?
|
Weapons | 1 | 2010 | 2 | 0.090 |
Why?
|
Electroshock | 1 | 2010 | 36 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2015 | 7029 | 0.090 |
Why?
|
Histocytochemistry | 1 | 2009 | 149 | 0.080 |
Why?
|
Electrocardiography | 2 | 2002 | 601 | 0.080 |
Why?
|
Melanoma | 1 | 2013 | 335 | 0.080 |
Why?
|
Platinum | 1 | 2009 | 17 | 0.080 |
Why?
|
Biophysics | 1 | 2009 | 41 | 0.080 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2008 | 13 | 0.080 |
Why?
|
Electrophysiology | 1 | 2009 | 160 | 0.080 |
Why?
|
Skin Neoplasms | 1 | 2013 | 375 | 0.080 |
Why?
|
Software | 3 | 2007 | 418 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2015 | 304 | 0.080 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 160 | 0.080 |
Why?
|
Gold | 1 | 2009 | 76 | 0.080 |
Why?
|
Energy Transfer | 2 | 2008 | 25 | 0.080 |
Why?
|
Brain | 1 | 2018 | 2176 | 0.080 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2008 | 84 | 0.080 |
Why?
|
Thermometry | 2 | 2020 | 2 | 0.070 |
Why?
|
Copper | 1 | 2009 | 149 | 0.070 |
Why?
|
Radiology, Interventional | 1 | 2007 | 21 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2007 | 123 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2007 | 36 | 0.070 |
Why?
|
Steam | 1 | 2006 | 5 | 0.070 |
Why?
|
Thigh | 1 | 2006 | 27 | 0.070 |
Why?
|
Necrosis | 2 | 2006 | 239 | 0.070 |
Why?
|
Computers | 1 | 2006 | 63 | 0.070 |
Why?
|
Thermodilution | 1 | 2005 | 20 | 0.070 |
Why?
|
Transducers | 1 | 2005 | 21 | 0.070 |
Why?
|
Convection | 1 | 2005 | 4 | 0.060 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2006 | 61 | 0.060 |
Why?
|
Hepatic Artery | 1 | 2005 | 25 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2011 | 2324 | 0.060 |
Why?
|
Cardiac Output | 1 | 2005 | 133 | 0.060 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 208 | 0.060 |
Why?
|
Nephrectomy | 1 | 2005 | 103 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2008 | 419 | 0.060 |
Why?
|
Specimen Handling | 1 | 2005 | 47 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2007 | 475 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 940 | 0.060 |
Why?
|
Sound | 1 | 2003 | 16 | 0.060 |
Why?
|
Rats, Inbred BN | 1 | 2003 | 51 | 0.060 |
Why?
|
Echocardiography | 1 | 2006 | 515 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 371 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2006 | 396 | 0.050 |
Why?
|
Rheology | 1 | 2002 | 25 | 0.050 |
Why?
|
Kidney | 2 | 2005 | 945 | 0.050 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2003 | 85 | 0.050 |
Why?
|
Electromagnetic Fields | 1 | 2002 | 66 | 0.050 |
Why?
|
Incidence | 1 | 2006 | 1603 | 0.050 |
Why?
|
Research Design | 1 | 2006 | 729 | 0.050 |
Why?
|
Risk Factors | 2 | 2011 | 5731 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2003 | 446 | 0.040 |
Why?
|
Tumor Burden | 2 | 2013 | 132 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2021 | 618 | 0.040 |
Why?
|
Intellectual Property | 1 | 2019 | 2 | 0.040 |
Why?
|
Neurological Rehabilitation | 1 | 2019 | 12 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2002 | 249 | 0.040 |
Why?
|
Ultrasonography, Doppler | 2 | 2012 | 57 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 213 | 0.040 |
Why?
|
Hemodynamics | 1 | 2001 | 705 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2017 | 108 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 2791 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2015 | 2550 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 138 | 0.030 |
Why?
|
Risk Assessment | 3 | 2010 | 2007 | 0.030 |
Why?
|
Rats | 1 | 2003 | 5300 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 114 | 0.030 |
Why?
|
Medical Staff | 1 | 2013 | 5 | 0.030 |
Why?
|
Survival Analysis | 2 | 2007 | 714 | 0.030 |
Why?
|
Aged | 1 | 2009 | 14862 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2013 | 45 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2013 | 69 | 0.030 |
Why?
|
Bevacizumab | 1 | 2012 | 34 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2013 | 219 | 0.030 |
Why?
|
Anisotropy | 2 | 2002 | 105 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2013 | 305 | 0.020 |
Why?
|
Patient-Specific Modeling | 1 | 2011 | 18 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2011 | 51 | 0.020 |
Why?
|
Lipids | 1 | 2013 | 298 | 0.020 |
Why?
|
Middle Aged | 1 | 2009 | 21147 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 346 | 0.020 |
Why?
|
Physicians | 1 | 2013 | 324 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2010 | 218 | 0.020 |
Why?
|
Biomarkers | 1 | 2015 | 1593 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 329 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2007 | 33 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2007 | 48 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2007 | 63 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2007 | 306 | 0.020 |
Why?
|
Electronics, Medical | 1 | 2005 | 4 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2005 | 101 | 0.020 |
Why?
|
Postoperative Period | 1 | 2005 | 238 | 0.020 |
Why?
|
Culture Techniques | 1 | 2003 | 65 | 0.010 |
Why?
|
Sus scrofa | 1 | 2003 | 74 | 0.010 |
Why?
|
Equipment Safety | 1 | 2003 | 50 | 0.010 |
Why?
|
Laser Therapy | 1 | 2003 | 54 | 0.010 |
Why?
|
Calibration | 1 | 2002 | 73 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2003 | 1174 | 0.010 |
Why?
|
Materials Testing | 1 | 2002 | 263 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2003 | 150 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2003 | 800 | 0.010 |
Why?
|
Pilot Projects | 1 | 2003 | 1342 | 0.010 |
Why?
|
Prognosis | 1 | 2003 | 2093 | 0.010 |
Why?
|